ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AbbVie, Harvard University collaborate for research on emergent viral diseases
August 31, 2020This collaboration aims to rapidly integrate fundamental biology into the preclinical and clinical development of new therapies for viral diseases that address a variety of therapeutic modalities. -
Ology Bioservices Inks $27M DoD Deal
April 26, 2020To adapt Veroplex cell platform for rapid response to viral threats for Department of Defense. -
Ascletis Pharma to develop Alphamab’s viral diseases drug in China
January 16, 2019Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment of viral diseases such as hepatitis B in Greater China.... -
Emergex Enters into MoU with Brazil’s Fiocruz to Develop Novel Vaccines Against Viral Diseases
December 03, 2018Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious ..... -
New uses for existing antiviral drugs
April 28, 2018A test of 55 antiviral drugs that are known to be safe in humans found 7 compounds that show new effects against multiple viruses…
Pharma Sources Insight January 2025
